Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2015 Jun 30;11(8):2068–2076. doi: 10.1080/21645515.2015.1010890

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2016 The Author(s). Published with license by Taylor & Francis Group, LLC

This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License http://creativecommons.org/licenses/by-nc/3.0/, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The moral rights of the named author(s) have been asserted.

PMC Copyright notice

Figure 3. — Histopathological changes in the placenta (hematoxylin-eosin; magnification, ×200, A–C) and immunohistochemical staining (magnification, ×200, D–F: DAB staining, G: DAB and AP-Red staining). (A) Section of placenta from late pregnancy of a healthy woman. (B) Section of placenta from a woman in the control group (HBV-infected women without HBIG injections). (C) Section of placenta from a woman in the experimental group (HBV-infected women receiving HBIG injections). Black arrows: syncytial knotting; white arrows: fibrinoid necrosis. (D) HBsAg staining. (E) HBIG staining. White arrow: villous capillary endothelial cells. (F) CD68 staining. Black arrows: Hofbauer cells. (G) CD68- and HBIG-double-positive immunohistochemical staining. Black arrow: HBIG in Hofbauer cells. (H) Comparison of HBIG intensity between the groups.